The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Genetics of Rheumatoid Arthritis — A Comprehensive Review
Open accessAbstract
The “Bermuda triangle” of genetics, environment and autoimmunity is involved in the pathogenesis of rheumatoid arthritis (RA). Various aspects of genetic contribution to the etiology, pathogenesis and outcome of RA are discussed in this review. The heritability of RA has been estimated to be about 60 %, while the contribution of HLA to heritability has been estimated to be 11–37 %. Apart from known shared epitope (SE) alleles, such as HLA-DRB1*01 and DRB1*04, other HLA alleles, such as HLA-DRB1*13 and DRB1*15 have been linked to RA susceptibility. A novel SE classification divides SE alleles into S1, S2, S3P and S3D groups, where primarily S2 and S3P groups have been associated with predisposition to seropositive RA. The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4. Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis. HLA and some non-HLA genes may differentiate between anti-citrullinated protein antibody (ACPA) seropositive and seronegative RA. Genetic susceptibility has also been associated with environmental factors, primarily smoking. Some GWAS studies carried out in rodent models of arthritis have confirmed the role of human genes. For example, in the collagen-induced (CIA) and proteoglycan-induced arthritis (PgIA) models, two important loci — Pgia26/Cia5 and Pgia2/Cia2/Cia3, corresponding the human PTPN22/CD2 and TRAF1/C5 loci, respectively — have been identified. Finally, pharmacogenomics identified SNPs or multiple genetic signatures that may be associated with responses to traditional disease-modifying drugs and biologics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
BIRAC Consortium, Stahl, E. A., YEAR Consortium, Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.582 · Cited by 1,253
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins
MacGregor, A. J., Snieder, H., Rigby, A. S., Koskenvuo, M., Kaprio, J., Aho, K., & Silman, A. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<30::aid-anr5>3.0.co;2-b · Cited by 1,178
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1206 · Cited by 1,168
Epidemiology of adult rheumatoid arthritis
ALAMANOS, Y., & DROSOS, A. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.09.002 · Cited by 916
TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
Plenge, R. M., Seielstad, M., Padyukov, L., Lee, A. T., Remmers, E. F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies, L. R. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073491 · Cited by 823
The Wellcome Trust Case Control Consortium (2010) · Nature · doi:10.1038/nature08979 · Cited by 807
Padyukov, L., Silva, C., Stolt, P., Alfredsson, L., & Klareskog, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20553 · Cited by 682
Huizinga, T. W. J., Amos, C. I., van der Helm‐van Mil, A. H. M., Chen, W., van Gaalen, F. A., Jawaheer, D., Schreuder, G. M. T., Wener, M., Breedveld, F. C., Ahmad, N., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21385 · Cited by 593
Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126532 · Cited by 409
Gaujoux-Viala, C., Smolen, J. S., Landewé, R., Dougados, M., Kvien, T. K., Mola, E. M., Scholte-Voshaar, M., van Riel, P., & Gossec, L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127225 · Cited by 360
Pedersen, M., Jacobsen, S., Klarlund, M., Pedersen, B. V., Wiik, A., Wohlfahrt, J., & Frisch, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2022 · Cited by 358
Proteoglycan‐induced arthritis in balb/c mice
Glant, T. T., Mikecz, K., Arzoumanian, A., & Poole, A. R. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300211 · Cited by 304
Self-citationA regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility
Kochi, Y., Okada, Y., Suzuki, A., Ikari, K., Terao, C., Takahashi, A., Yamazaki, K., Hosono, N., Myouzen, K., Tsunoda, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.583 · Cited by 267
van der Woude, D., Houwing‐Duistermaat, J. J., Toes, R. E. M., Huizinga, T. W. J., Thomson, W., Worthington, J., van der Helm‐van Mil, A. H. M., & de Vries, R. R. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24385 · Cited by 250
Smoking as a trigger for inflammatory rheumatic diseases
Klareskog, L., Padyukov, L., & Alfredsson, L. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32801127c8 · Cited by 211
Klareskog, L., Padyukov, L., Lorentzen, J., & Alfredsson, L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0249 · Cited by 207
du Montcel, S. T., Michou, L., Petit‐Teixeira, E., Osorio, J., Lemaire, I., Lasbleiz, S., Pierlot, C., Quillet, P., Bardin, T., Prum, B., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20989 · Cited by 198
Pathophysiology of rheumatoid arthritis
Cooles, F. A., & Isaacs, J. D. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834518a3 · Cited by 186
Genetics of rheumatoid arthritis: what have we learned?
Bax, M., van Heemst, J., Huizinga, T. W. J., & Toes, R. E. M. (2011) · Immunogenetics · doi:10.1007/s00251-011-0528-6 · Cited by 170
Lee, H., Irigoyen, P., Kern, M., Lee, A., Batliwalla, F., Khalili, H., Wolfe, F., Lum, R. F., Massarotti, E., Weisman, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22703 · Cited by 163
van der Woude, D., Lie, B. A., Lundström, E., Balsa, A., Feitsma, A. L., Houwing‐Duistermaat, J. J., Verduijn, W., Nordang, G. B. N., Alfredsson, L., Klareskog, L., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27366 · Cited by 159
An overview on the genetic of rheumatoid arthritis: A never-ending story
Perricone, C., Ceccarelli, F., & Valesini, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.021 · Cited by 159
Plant, D., Bowes, J., Potter, C., Hyrich, K. L., Morgan, A. W., Wilson, A. G., Isaacs, J. D., British Society for Rheumatology Biologics Register, & Barton, A. C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30130 · Cited by 153
Ding, B., Padyukov, L., Lundström, E., Seielstad, M. T., Plenge, R. M., Oksenberg, J. R., Gregersen, P. K., Alfredsson, L. S., & Klareskog, L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24135 · Cited by 145
Mil, A. H. M. V. D. H., Verpoort, K. N., le Cessie, S., Huizinga, T. W. J., de Vries, R. R. P., & Toes, R. E. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22373 · Cited by 142
Faragó, B., Magyari, L., Sáfrány, E., Csöngei, V., Járomi, L., Horvatovich, K., Sipeky, C., Maász, A., Radics, J., Gyetvai, Á., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072819 · Cited by 130
Self-citationProteoglycan-Induced Arthritis: Immune Regulation, Cellular Mechanisms, and Genetics
Glant, T. T., Finnegan, A., & Mikecz, K. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i3.20 · Cited by 129
Self-citationVerpoort, K. N., Cheung, K., Ioan‐Facsinay, A., Mil, A. H. M. V. D. H., Vries-Bouwstra, J. K. D., Allaart, C. F., Drijfhout, J. W., de Vries, R. R. P., Breedveld, F. C., Huizinga, T. W. J., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23127 · Cited by 127
Understanding the genetic contribution to rheumatoid arthritis
Mil, A. H. M. V. D. H., Wesoły, J., & Huizinga, T. W. J. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000160780.13012.be · Cited by 119
Meskó, B., Poliskal, S., Szegedi, A., Szekanecz, Z., Palatka, K., Papp, M., & Nagy, L. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-15 · Cited by 116
Self-citationJawaheer, D., Thomson, W., MacGregor, A. J., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370511 · Cited by 97
van der Linden, M. P. M., Feitsma, A. L., le Cessie, S., Kern, M., Olsson, L. M., Raychaudhuri, S., Begovich, A. B., Chang, M., Catanese, J. J., Kurreeman, F. A. S., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24721 · Cited by 96
Ruyssen‐Witrand, A., Rouanet, S., Combe, B. G., Dougados, M., Loët, X. L., Sibilia, J., Tébib, J., Mariette, X., & Constantin, A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200337 · Cited by 94
Are ACPA-positive and ACPA-negative RA the same disease?
Daha, N. A., & Toes, R. E. M. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.28 · Cited by 88
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis
Liang, Y.-L., Wu, H., Shen, X., Li, P.-Q., Yang, X.-Q., Liang, L., Tian, W.-H., Zhang, L.-F., & Xie, X.-D. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1754-1 · Cited by 88
Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?
Szekanecz, Z., Soós, L., Szabó, Z., Fekete, A., Kapitány, A., Végvári, A., Sipka, S., Szűcs, G., Szántó, S., & Lakos, G. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8022-5 · Cited by 86
Self-citationTolusso, B., Pietrapertosa, D., Morelli, A., Santis, M. D., Gremese, E., Farina, G., Carniello, S. G., Del Frate, M., & Ferraccioli, G. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.5.683 · Cited by 81
van der Woude, D., Alemayehu, W. G., Verduijn, W., de Vries, R. R. P., Houwing‐Duistermaat, J. J., Huizinga, T. W. J., & Toes, R. E. M. (2010) · Nature Genetics · doi:10.1038/ng1010-814 · Cited by 76
Genetics of rheumatoid arthritis: time for a change!
de Vries, R. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283457524 · Cited by 72
Pharmacogenetics: implications for therapy in rheumatic diseases
Davila, L., & Ranganathan, P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.117 · Cited by 64
Genome-wide searching of rare genetic variants in WTCCC data
Feng, T., & Zhu, X. (2010) · Human Genetics · doi:10.1007/s00439-010-0849-9 · Cited by 60
Goëb, V., Dieudé, P., Daveau, R., Thomas-L'Otellier, M., Jouen, F., Hau, F., Boumier, P., Tron, F., Gilbert, D., Fardellone, P., et al. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken192 · Cited by 57
Scott, I. C., Steer, S. E., Lewis, C. M., & Cope, A. P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.010 · Cited by 56
Associations Between FCGR3A Polymorphisms and Susceptibility to Rheumatoid Arthritis: A Metaanalysis
Lee, Y. H., Ji, J. D., & Song, G. G. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080186 · Cited by 47
Ahlqvist, E., Hultqvist, M. H., & Holmdahl, R. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2600 · Cited by 33
Pharmacogenetics of Etanercept in Rheumatoid Arthritis
Danila, M. I., Hughes, L. B., & Bridges, S. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1011 · Cited by 30
Meskó, B., Póliska, S., Szamosi, S., Szekanecz, Z., Podani, J., Váradi, C., Guttman, A., & Nagy, L. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110961 · Cited by 27
Self-citationSmoking and inflammatory diseases
Vittecoq, O., Lequerré, T., Goëb, V., Loët, X. L., Aït-Abdesselam, T., & Klemmer, N. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.09.011 · Cited by 26
Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis
Centola, M. B., Szekanecz, Z., Kiss, E. V., Zeher, M., Szegedi, G., Nakken, B., & Szodoray, P. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.5.797 · Cited by 5
Self-citation
Cited by
Smolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Genetic and environmental risk factors for rheumatoid arthritis
Deane, K. D., Demoruelle, M. K., Kelmenson, L. B., Kuhn, K. A., Norris, J. M., & Holers, V. M. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.08.003 · Cited by 666
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Lawlor, K. E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B. A., D’Cruz, A. A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7282 · Cited by 649
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Weeks, E. M., Ulirsch, J. C., Cheng, N. Y., Trippe, B. L., Fine, R. S., Miao, J., Patwardhan, T. A., Kanai, M., Nasser, J., Fulco, C. P., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01443-6 · Cited by 349
Metadata
- Authors
- Kurkó, J., Besenyei, T., Laki, J., Glant, T. T., Mikecz, K., & Szekanecz, Z.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2013-01-05
- Volume
- 45
- Issue
- 2
- Pages
- 170-179
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W2064551563
- Cited by
- 343
- References
- 50
- FWCI
- 20.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.